Skip to main content

CT Coronary Calcium Scoring (CAC Score): A Practical, Evidence-Based Guide for Clinicians


CT Coronary Calcium Scoring (CAC Score): A Practical, Evidence-Based Guide for Clinicians


Introduction


CT coronary calcium scoring is a non-invasive, rapid, and widely validated tool for quantifying coronary atherosclerotic burden. By detecting and measuring calcified plaque in the coronary arteries, the CAC score refines cardiovascular risk assessment beyond traditional risk factors and directly influences preventive cardiology decisions—especially statin initiation and intensity.



---


What Is CT Coronary Calcium Scoring?


Coronary calcium scoring uses non-contrast, ECG-gated cardiac CT to detect calcified atherosclerotic plaques in the coronary arteries. The amount of calcium is quantified as an Agatston score, which correlates strongly with total plaque burden and future atherosclerotic cardiovascular disease (ASCVD) events.



---


How the Test Is Performed


Scan type: Non-contrast, ECG-gated CT


Scan time: ~5–10 minutes


Radiation dose: Low (≈1 mSv or less with modern scanners)


Preparation: No fasting; beta-blockers usually not required


Contrast: Not used




---


The Agatston Score: Interpretation


CAC Score Interpretation Clinical Meaning


0 No detectable calcium Very low short-term risk

1–99 Mild calcification Early atherosclerosis

100–299 Moderate calcification Definite CAD

≥300 Severe calcification High ASCVD risk



Percentile-based interpretation (age, sex, ethnicity) further refines risk, particularly in younger patients.



---


Clinical Indications (Most Useful Scenarios)


✅ Primary Prevention (Key Role)


Adults 40–75 years


Borderline or intermediate ASCVD risk (5–20%)


Uncertainty about starting statins



✅ Risk Reclassification


Strong family history of premature CAD


Metabolic syndrome


Chronic inflammatory conditions


Patients reluctant to start lifelong statin therapy



❌ Not Routinely Indicated In


Known CAD or prior MI/PCI/CABG


Symptomatic patients (use CCTA or stress testing)


Very low-risk young adults


Advanced CKD (interpret cautiously)




---


CAC Score and Statin Decision-Making


Guideline-based approach (ACC/AHA):


CAC = 0

→ Consider deferring statin (except in diabetes, smokers, strong FHx)


CAC 1–99

→ Statin favored (especially age >55)


CAC ≥100 or ≥75th percentile

→ Statin therapy clearly indicated



Higher CAC = higher statin intensity consideration



---


Prognostic Value: Why CAC Matters


CAC is one of the strongest predictors of future coronary events


Outperforms traditional risk factors alone


Provides “warranty period”:


CAC 0 → ~5–10 years of very low event rates



Predicts:


MI


Cardiovascular mortality


All-cause mortality





---


CAC vs Other Cardiac Tests


Test What It Detects Best Use


CAC Score Calcified plaque burden Risk stratification

CCTA Lumen + soft plaque Symptomatic patients

Stress Test Ischemia Functional assessment

Carotid IMT Arterial thickness Limited predictive value



Key Point: CAC does not assess stenosis or ischemia.



---


Special Clinical Situations


Diabetes Mellitus


CAC refines risk even in diabetics


CAC = 0 identifies a lower-risk subgroup



Young Patients (<45 years)


Any CAC is abnormal


Suggests premature atherosclerosis



Women


CAC improves risk prediction where traditional scores may underestimate risk




---


Limitations of Calcium Scoring


Does not detect non-calcified (soft) plaques


Zero score ≠ zero lifetime risk


Cannot assess lesion severity or ischemia


Incidental extracardiac findings may occur




---


Follow-Up and Repeat Scanning


CAC = 0: Repeat in 5 years (earlier if risk factors worsen)


CAC >0: Repeat usually not required; focus on aggressive risk modification




---


Practical Take-Home Points


CAC score is a powerful, cost-effective preventive cardiology tool


Best used in borderline–intermediate risk adults


Strongly guides statin decisions


CAC = 0 provides reassurance; CAC ≥100 mandates action


Complements—but does not replace—clinical judgment




---


Summary


CT coronary calcium scoring bridges the gap between population-based risk calculators and individual patient risk. Its ability to visualize subclinical atherosclerosis makes it one of the most impactful investigations in modern preventive cardiology. When used appropriately, CAC scoring improves patient adherence, personalizes therapy, and ultimately reduces cardiovascular events.



Comments

Popular posts from this blog

Brugada ECG vs Incomplete Right Bundle Branch Block (iRBBB)

Brugada ECG vs Incomplete Right Bundle Branch Block (iRBBB) Why this differentiation matters Brugada pattern is a malignant channelopathy associated with sudden cardiac death, while incomplete RBBB is usually a benign conduction variant. Mislabeling Brugada as iRBBB can be fatal; overcalling iRBBB as Brugada can lead to unnecessary anxiety and ICD implantation. --- 1. Basic Definitions Brugada ECG Pattern Primary repolarization abnormality Genetic sodium-channel disorder Characteristic ST-segment elevation in V1–V3 Risk of ventricular fibrillation and sudden death Incomplete RBBB (iRBBB) Depolarization abnormality Delay in right ventricular conduction Common in healthy individuals Usually asymptomatic and benign --- 2. ECG Morphology: Side-by-Side Comparison QRS Duration Brugada: QRS usually <120 ms iRBBB: QRS <120 ms, but with RBBB morphology --- V1–V2 Pattern (Key Differentiator) Brugada Pseudo-RBBB appearance ST elevation ≥2 mm ST segment is coved or saddleback Terminal QRS bl...

Acute Treatment of Hyperkalemia

Acute Treatment of Hyperkalemia – A Practical, Bedside-Oriented Guide Hyperkalemia is a potentially life-threatening electrolyte abnormality that demands prompt recognition and decisive management. The danger lies not only in the absolute potassium value but in its effects on cardiac conduction, which can rapidly progress to fatal arrhythmias. Acute treatment focuses on three parallel goals: stabilizing the cardiac membrane, shifting potassium into cells, and removing excess potassium from the body. Understanding this stepwise approach helps clinicians act quickly and rationally in emergency settings. Why Hyperkalemia Is Dangerous Potassium plays a key role in maintaining the resting membrane potential of cardiac myocytes. Elevated serum potassium reduces the transmembrane gradient, leading to slowed conduction, ECG changes, ventricular arrhythmias, and asystole. Importantly, ECG changes do not always correlate with potassium levels, so treatment decisions should be based on clinical c...

π˜Όπ™£π™©π™žπ™˜π™€π™–π™œπ™ͺπ™‘π™–π™©π™žπ™€π™£ π˜Όπ™›π™©π™šπ™§ π™Žπ™©π™§π™€π™ π™š

 π˜Όπ™£π™©π™žπ™˜π™€π™–π™œπ™ͺπ™‘π™–π™©π™žπ™€π™£ π˜Όπ™›π™©π™šπ™§ π™Žπ™©π™§π™€π™ π™š in  Patient with AF and acute IS/TIA European Heart Association Guideline recommends: • 1 days after TIA • 3 days after mild stroke • 6 days after moderate stroke • 12 days after severe stroke Early anticoagulation can decrease a risk of recurrent stroke and embolic events but may increase a risk of secondary hemorrhagic transformation of brain infarcts.  The 1-3-6-12-day rule is a known consensus with graded increase in delay of anticoagulation between 1 and 12 days after onset of ischemic stroke or transient ischemic attack(TIA), according to neurological severity based on European expert opinions. However, this rule might be somewhat later than currently used in a real-world practical setting.